top of page

OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML

Product details

Registration number: SIN16871P

Classification: Prescription Only

Active ingredients: Ocrelizumab

Strength: 300 mg/10 ml

Dosage form: INJECTION, SOLUTION, CONCENTRATE

Route: INTRAVENOUS

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: L04AG08

HSA approval date: 28 September 2023

Manufacturer(s):

  • Roche Diagnostics GmbH
  • F. Hoffmann-La Roche Ltd

Manufacturing country/countries: SWITZERLAND; GERMANY

What are the HSA registration number and classification for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16871P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ocrelizumab

Strength: 300 mg/10 ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION, CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Roche Diagnostics GmbH
  • F. Hoffmann-La Roche Ltd

Manufacturing country/countries: SWITZERLAND; GERMANY

Source for this answer

Where can I look up OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16871P or the exact product name OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16871P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page